p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder

BJU International

Volumn 88, Issue 3, 2001, Pages 202-208

  Rotterud R ^a   Berner, A ^a   Holm, R ^a   Skovlund, E ^a   Fossa S D ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bladder neoplasms; Immunohistochemistry; p53; Protein; Radiation; Radiation effects; Radiobiology; Radiotherapy; Tolerance

Indexed keywords

PROTEIN MDM2; PROTEIN P21; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIVITY; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NUCLEAR PROTEINS; ONCOGENE PROTEIN P21(RAS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0034834191     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2001.02268.x     Document Type: Article

References (44)

1. Radiotherapy in bladder cancer
2. A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer
3. Twenty years of p53 research: Structural and functional aspects of the p53 protein
4. Functions of the MDM2 oncoprotein
5. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage
6. Functional role of p21 during the cellular response to stress
7. Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy
8. Relationship between radiation response and p53 status in human bladder cancer cells
9. Further investigation of the response of human uroepithelium to low doses of cobalt-60 gamma radiation
10. p53 and Rb immunostaining in locally advanced bladder cancer: Relation to prognostic variables and predictive value for the local response to radical radiotherapy
11. Prognostic factors in muscle invasive bladder cancer treated with radiotherapy
12. Cell-cycle arrest versus cell death in cancer therapy
13. Relationship between expression of p21WAF1/CIP1 and radioresistance in human gliomas
14. The clinical significance of p21 (WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma
15. The radiation-induced S-phase checkpoint is independent of CDKN1A
16. Expression of p53 and p21 proteins in oral squamous cell carcinoma: Correlation with lymph node metastasis and response to chemoradiotherapy
17. Urological tumours
18. The histology of radiation therapy effect on prostate adenocarcinoma as assessed by needle biopsy after brachytherapy boost. Correlation with biochemical failure
19. Apoptosis induced by X-irradiation of rec-myc cells is postmitotic and not predicted by the time after irradiation or behavior of sister cells
20. An in vitro 125IUdR-release assay for measuring the kinetics of cell death
21. Abnormal pattern of post-gamma-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome
22. Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity
23. Transfection of a vector expressing wild-type p53 into cells of two human glioma cell lines enhances radiation toxicity
24. Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells
25. Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation
26. Transformation and radiosensitivity of human diploid skin fibroblasts transfected with SV40 T-antigen mutants defective in RB and P53 binding domains
27. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo
28. p53 status and the efficacy of cancer therapy in vivo
29. p53 mutations predict non-small cell lung carcinoma response to radiotherapy
30. p53 gene alterations in prostate cancer after radiation failure and their association with clinical outcome: A molecular and immunohistochemical analysis
31. Cytogenetic response to G2-phase X irradiation in relation to DNA repair and radiosensitivity in a cancer-prone family with Li-Fraumeni syndrome
32. Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresis
33. P53 protein overexpression predicts complete response to chemoradiation therapy in T2-T4 bladder cancer
34. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
35. Differential cell cycle checkpoint response in normal human keratinocytes and fibroblasts
36. Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light
37. Different responses of epidermal and hair follicular cells to radiation correlate with distinct patterns of p53 and p21 induction
38. A point mutation of human p53, which was not detected as a mutation by a yeast functional assay, led to apoptosis but not p21Waf1/ Cip1/Sdi1 expression in response to ionizing radiation in a human osteosarcoma cell line, Saos-2
39. Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast
40. Effect of p53 overexpression on radiation sensitivity of human colon cancer cells
41. Thymocyte apoptosis induced by p53-dependent and independent pathways
42. Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress
43. Induction of apoptosis in HeLa cells by trans-activation-deficient p53
44. p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns